Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Prochlorococcus marinus N-acetyl-gamma-glutamyl-phosphate reductase (argC) CSB-YP381270PZB
CSB-EP381270PZB
CSB-BP381270PZB
CSB-MP381270PZB
CSB-EP381270PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Leucine--tRNA ligase (leuS), partial CSB-YP381271PZB
CSB-EP381271PZB
CSB-BP381271PZB
CSB-MP381271PZB
CSB-EP381271PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 50S ribosomal protein L33 (rpmG) CSB-YP381272PZB
CSB-EP381272PZB
CSB-BP381272PZB
CSB-MP381272PZB
CSB-EP381272PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Crossover junction endodeoxyribonuclease RuvC (ruvC) CSB-YP381273PZB
CSB-EP381273PZB
CSB-BP381273PZB
CSB-MP381273PZB
CSB-EP381273PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Recombination protein RecR (recR) CSB-YP381274PZB
CSB-EP381274PZB
CSB-BP381274PZB
CSB-MP381274PZB
CSB-EP381274PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Methylenetetrahydrofolate--tRNA- (uracil-5-)-methyltransferase TrmFO CSB-YP381275PZB
CSB-EP381275PZB
CSB-BP381275PZB
CSB-MP381275PZB
CSB-EP381275PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Photosystem II protein Y (psbY), partial CSB-YP381276PZB
CSB-EP381276PZB
CSB-BP381276PZB
CSB-MP381276PZB
CSB-EP381276PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Photosystem I assembly protein Ycf4 (ycf4), partial CSB-YP381277PZB1
CSB-EP381277PZB1
CSB-BP381277PZB1
CSB-MP381277PZB1
CSB-EP381277PZB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Serine--tRNA ligase (serS) CSB-YP381278PZB
CSB-EP381278PZB
CSB-BP381278PZB
CSB-MP381278PZB
CSB-EP381278PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Thiamine-phosphate synthase (thiE) CSB-YP381279PZB
CSB-EP381279PZB
CSB-BP381279PZB
CSB-MP381279PZB
CSB-EP381279PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Glycerol-3-phosphate acyltransferase (plsY), partial CSB-YP381280PZB1
CSB-EP381280PZB1
CSB-BP381280PZB1
CSB-MP381280PZB1
CSB-EP381280PZB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP381281PZB
CSB-EP381281PZB
CSB-BP381281PZB
CSB-MP381281PZB
CSB-EP381281PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus DNA-directed RNA polymerase subunit gamma (rpoC1), partial CSB-YP381282PZB
CSB-EP381282PZB
CSB-BP381282PZB
CSB-MP381282PZB
CSB-EP381282PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus LL-diaminopimelate aminotransferase (dapL) CSB-YP381283PZB
CSB-EP381283PZB
CSB-BP381283PZB
CSB-MP381283PZB
CSB-EP381283PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Photosystem I P700 chlorophyll a apoprotein A1 (psaA), partial CSB-YP381284PZB
CSB-EP381284PZB
CSB-BP381284PZB
CSB-MP381284PZB
CSB-EP381284PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 30S ribosomal protein S11 (rpsK) CSB-YP381285PZB
CSB-EP381285PZB
CSB-BP381285PZB
CSB-MP381285PZB
CSB-EP381285PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 30S ribosomal protein S5 (rpsE) CSB-YP381286PZB
CSB-EP381286PZB
CSB-BP381286PZB
CSB-MP381286PZB
CSB-EP381286PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 50S ribosomal protein L5 (rplE) CSB-YP381287PZB
CSB-EP381287PZB
CSB-BP381287PZB
CSB-MP381287PZB
CSB-EP381287PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 50S ribosomal protein L22 (rplV) CSB-YP381288PZB
CSB-EP381288PZB
CSB-BP381288PZB
CSB-MP381288PZB
CSB-EP381288PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus NAD (P)H-quinone oxidoreductase subunit N CSB-YP381289PZB
CSB-EP381289PZB
CSB-BP381289PZB
CSB-MP381289PZB
CSB-EP381289PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>